BeStock  
Stocks › Biotechnology › LKFT

Lakefront Biotherapeutics LKFT

US equityMarket cap rank #2805Biotechnology
$29.51 +$0.14 (+0.48%)
Pre-market · Oct 6, 4:10 am ET · After hours $29.51 0.00%
Open$29.38
Prev close$29.37
Day range$29.24 – $29.91
Volume439.7K
Market cap$1.93B
P/E (TTM)2.9
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership95.6%+1.97 pts vs. prior quarter
Institutions holding123+0 vs. prior quarter
Short interest5.21% of floatDays to cover 12.4 · as of 15 Sep 2026
Short-sale volume share23.3%5-day average of daily volume

Short-sale volume as % of daily volume

11%18%25%32%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$3.47M (9 inflow days, 11 outflow days).

The five largest holders on file together own 74.7% of shares outstanding.

Largest holders

  • Gilead Sciences, Inc.51.36%
  • Tang Capital Management, LLC7.77%
  • Van Herk Investments B.V.7.12%
  • Madison Avenue Partners, LP5.30%
  • Prosight Management, LP3.14%
  • Vanguard Capital Management, LLC3.08%
  • EcoR1 Capital, LLC2.56%
  • Bank of America Corporation2.19%

By investor type

  • Public Company53.72%
  • Mutual Fund18.88%
  • Hedge Fund13.84%
  • VC/PE Fund7.12%
  • Sovereign Wealth Fund1.57%
  • Private Company0.31%
  • Insurance Company0.18%
  • Individual/Insider0.01%

Reported short interest has risen from 3.40% to 5.21% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 3,413,512 5.2% 12.4
31 Aug 2026 3,295,220 5.0% 14.0
14 Aug 2026 2,972,977 4.5% 10.2
31 Jul 2026 2,521,939 3.9% 14.1
15 Jul 2026 2,323,166 3.5% 16.2
30 Jun 2026 2,238,240 3.4% 15.8

Discussion

No comments yet — be the first to weigh in on LKFT.

Leave a comment

Scroll to Top